Informa’s (INF) “Buy” Rating Reiterated at UBS Group

Informa (LON:INF)‘s stock had its “buy” rating restated by equities research analysts at UBS Group in a research note issued on Monday, investing.thisismoney.co.uk reports.

A number of other equities research analysts have also issued reports on the company. Morgan Stanley lowered Informa to an “equal weight” rating and set a GBX 850 ($11.07) target price on the stock. in a research note on Thursday, August 16th. Deutsche Bank reaffirmed a “buy” rating on shares of Informa in a research note on Wednesday, September 12th. Peel Hunt reaffirmed a “hold” rating on shares of Informa in a research note on Wednesday, September 5th. Shore Capital reaffirmed a “buy” rating on shares of Informa in a research note on Monday, August 13th. Finally, Liberum Capital reaffirmed a “buy” rating on shares of Informa in a research note on Wednesday, July 25th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Informa presently has an average rating of “Buy” and a consensus target price of GBX 862.75 ($11.24).

INF stock opened at GBX 747.60 ($9.74) on Monday. Informa has a 1 year low of GBX 624.50 ($8.13) and a 1 year high of GBX 773 ($10.07).

About Informa

Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.

Featured Story: Do Tariffs Work?

Analyst Recommendations for Informa (LON:INF)

Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply